Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 37, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-03-13
DOI
10.1186/s13046-018-0719-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Insight into the Complexity of the i-Motif and G-Quadruplex DNA Structures Formed in the KRAS Promoter and Subsequent Drug-Induced Gene Repression
- (2017) Christine E. Kaiser et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation
- (2017) Candani S. A. Tutuka et al. Molecular Cancer
- Drugging RAS: Know the enemy
- (2017) Bjoern Papke et al. SCIENCE
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
- (2016) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Identification and characterization of a new G-quadruplex forming region within the kRAS promoter as a transcriptional regulator
- (2016) Rhianna K. Morgan et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- G4 DNA in ras genes and its potential in cancer therapy
- (2016) Susanna Cogoi et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- miR-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3
- (2016) Ying Zhou et al. CANCER RESEARCH
- Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer
- (2016) Filippo Pietrantonio et al. CLINICAL CANCER RESEARCH
- Recent advances in cancer drug discovery targeting RAS
- (2016) Candice Y. Wilson et al. DRUG DISCOVERY TODAY
- Patient-derived xenografts: a relevant preclinical model for drug development
- (2016) Luca Pompili et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Identification of pyrazolopyridazinones as PDEδ inhibitors
- (2016) Björn Papke et al. Nature Communications
- Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State
- (2016) M. P. Patricelli et al. Cancer Discovery
- LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer
- (2016) Eliza Vakana et al. Oncotarget
- Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers
- (2015) Sheng-Bin Peng et al. CANCER CELL
- KRAS as a Therapeutic Target
- (2015) F. McCormick CLINICAL CANCER RESEARCH
- Targeting G-Quadruplex DNA Structures by EMICORON Has a Strong Antitumor Efficacy against Advanced Models of Human Colon Cancer
- (2015) M. Porru et al. MOLECULAR CANCER THERAPEUTICS
- Prevention: Tending the gut
- (2015) Lauren Gravitz NATURE
- RAF inhibitors that evade paradoxical MAPK pathway activation
- (2015) Chao Zhang et al. NATURE
- High-throughput sequencing of DNA G-quadruplex structures in the human genome
- (2015) Vicki S Chambers et al. NATURE BIOTECHNOLOGY
- Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
- (2015) Giulia Siravegna et al. NATURE MEDICINE
- Targeting KRAS Oncogene in Colon Cancer Cells with 7-Carboxylate Indolo[3,2-b]quinoline Tri-Alkylamine Derivatives
- (2015) Hugo Brito et al. PLoS One
- Inhibition of KRAS codon 12 mutants using a novel DNA-alkylating pyrrole–imidazole polyamide conjugate
- (2015) Kiriko Hiraoka et al. Nature Communications
- Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer
- (2015) M. Russo et al. Cancer Discovery
- Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model
- (2015) Satyanarayana Rachagani et al. Oncotarget
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-mediated regulation of KRAS in cancer
- (2014) Minlee Kim et al. Journal of Hematology & Oncology
- Structure Guided Design and Kinetic Analysis of Highly Potent Benzimidazole Inhibitors Targeting the PDEδ Prenyl Binding Site
- (2014) Gunther Zimmermann et al. JOURNAL OF MEDICINAL CHEMISTRY
- Drugging the undruggable RAS: Mission Possible?
- (2014) Adrienne D. Cox et al. NATURE REVIEWS DRUG DISCOVERY
- Regulation of microRNA biogenesis
- (2014) Minju Ha et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
- (2014) D. A. E. Cross et al. Cancer Discovery
- NSAIDs Inhibit Tumorigenesis, but How?
- (2013) Evrim Gurpinar et al. CLINICAL CANCER RESEARCH
- MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targetingKRAS,PIK3CDandBCL2
- (2013) Wen-Ting Liao et al. JOURNAL OF PATHOLOGY
- K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
- (2013) Jonathan M. Ostrem et al. NATURE
- In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras-effector interaction
- (2013) F. Shima et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-Mediated Activation
- (2012) Qi Sun et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A Comprehensive Survey of Ras Mutations in Cancer
- (2012) I. A. Prior et al. CANCER RESEARCH
- Aromatic Core Extension in the Series of N-Cyclic Bay-Substituted Perylene G-Quadruplex Ligands: Increased Telomere Damage, Antitumor Activity, and Strong Selectivity for Neoplastic over Healthy Cells
- (2012) Marco Franceschin et al. ChemMedChem
- 5'-UTR RNA G-quadruplexes: translation regulation and targeting
- (2012) A. Bugaut et al. NUCLEIC ACIDS RESEARCH
- Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity
- (2012) T. Maurer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA Damage Persistence as Determinant of Tumor Sensitivity to the Combination of Topo I Inhibitors and Telomere-Targeting Agents
- (2011) A. Biroccio et al. CLINICAL CANCER RESEARCH
- The long march of antisense
- (2011) Dan Jones NATURE REVIEWS DRUG DISCOVERY
- Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?
- (2011) Shankar Balasubramanian et al. NATURE REVIEWS DRUG DISCOVERY
- miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras
- (2010) Ki-Hyuk Shin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miRNA-96 Suppresses KRAS and Functions as a Tumor Suppressor Gene in Pancreatic Cancer
- (2010) S. Yu et al. CANCER RESEARCH
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
- (2010) Sonja J. Heidorn et al. CELL
- PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy
- (2010) E Salvati et al. ONCOGENE
- The role of let-7 in cell differentiation and cancer
- (2009) Benjamin Boyerinas et al. ENDOCRINE-RELATED CANCER
- BRAFMutation in Metastatic Colorectal Cancer
- (2009) Jolien Tol et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of miR-143 targeting KRAS in colorectal tumorigenesis
- (2009) X Chen et al. ONCOGENE
- Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial
- (2008) Frank L. Meyskens et al. Cancer Prevention Research
- G-Quadruplex Ligand RHPS4 Potentiates the Antitumor Activity of Camptothecins in Preclinical Models of Solid Tumors
- (2008) C. Leonetti et al. CLINICAL CANCER RESEARCH
- Genomic and Epigenetic Instability in Colorectal Cancer Pathogenesis
- (2008) William M. Grady et al. GASTROENTEROLOGY
- Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer
- (2008) Jim Cassidy et al. JOURNAL OF CLINICAL ONCOLOGY
- Ras oncogenes: split personalities
- (2008) Antoine E. Karnoub et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started